Skip to content

An observational study on the risk factors of rebound tenderness after nerve block in thoracoscopic pulmonary surgery

An observational study on the risk factors of rebound tenderness after nerve block in thoracoscopic pulmonary surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060374
Enrollment
Unknown
Registered
2022-05-29
Start date
2022-05-18
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective thoracoscopic lung surgery

Interventions

None listed

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years old; 2. ASA classification I-III; 3. Patients scheduled for elective thoracoscopic lung surgery and nerve block.

Exclusion criteria

Exclusion criteria: 1. Contraindications for nerve block (abnormal bleeding or coagulation, local or systemic infection); 2. Patients with a history of chronic pain or long-term use of sedative and analgesic drugs; 3. Patients with a history of neurological, mental or neuromuscular diseases; 4. Patients who refuse to receive treatment; 5. Allergic to the test drug; 6. BMI = 30 kg/m2; 7. Patients with multiple injuries who need other surgery or analgesic drug treatment; 8. Patients with preoperative nerve injury; 9. Patients who do not have sufficient Chinese language skills and have a clear understanding of the Numerical Rating Scale (NRS) for pain cannot cooperate with pain assessment patients; 10. Patients and family members refuse to sign the informed consent; 11. Those who refuse to use PCIA after surgery.

Design outcomes

Primary

MeasureTime frame
VAS scores at rest at 2, 6, 12, 18, 24, 48 h after operation;VAS scores in motion at 2, 6, 12, 18, 24, 48 h after operation;

Countries

China

Contacts

Public ContactWang Xiaoliang

Nanjing First Hospital

wxl145381@163.com+86 13776615743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026